查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1989956

体外循环系统市场：全球市场按产品类型、组件、技术、应用和最终用户分類的预测——2026-2032年

Extracorporeal Circulation System Market by Product Type, Component, Technology, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，体外循环系统市场价值将达到 15.8 亿美元，到 2026 年将成长到 17 亿美元，到 2032 年将达到 27.8 亿美元，复合年增长率为 8.36%。

主要市场统计数据
基准年 2025 15.8亿美元
预计年份：2026年 17亿美元
预测年份 2032 27.8亿美元
复合年增长率 (%) 8.36%

本文檔定义了体外循环系统，并概述了影响采购和实施决策的不断变化的临床和技术要求。

现代体外循环系统领域，在持续的技术进步和不断发展的临床通讯协定的推动下，在心臟外科手术和高级呼吸支持的交叉领域中发挥核心作用。近年来，随着医院和专科医疗中心不断提升其处理复杂心血管手术和严重呼吸衰竭的能力，人们对心肺体外迴圈装置和体外膜氧合（ECMO）平台的关注度日益提高。本文将重点放在临床驱动因素、组件层面的创新以及影响采购和部署决策的政策环境，从而概述此生态系统。

找出正在迅速改变体外循环系统开发和实施的技术进步、临床实践演变和监管压力。

体外循环领域正经历一场变革，其驱动力来自于泵浦技术、氧合器设计和系统整合方面的创新，以及临床实践模式的转变和监管机构对安全性和实际应用性能的重视。离心式帮浦和磁浮泵因其溶血率低、流量控制更佳而日益普及，而氧合器的进步则侧重于气体交换效率和抗血栓性。这些技术进步催生了新的系统结构，这些架构强调整合解决方案、可携式平台和一次性组件策略，以降低交叉感染的风险。

了解近期关税趋势和贸易政策变化如何影响该行业的采购体系重新评估、成本调整和策略製造应对措施。

2025年美国实施的关税调整、贸易政策修订和进口限制的累积影响，将为体外循环生态系统中的製造商、经销商和终端用户带来许多复杂挑战。进口医疗组件和成品的关税变化可能会改变接收成本，促使企业重新评估筹资策略，并加速产能转移和近岸外包。因此，拥有全球供应链的企业必须调整其跨国采购惯例，以适应新的关税环境。

我们按产品、组件、技术、应用和最终用户进行细分，以确定差异化的临床需求和产业策略路径。

精准理解产品细分对于解读整个体外循环产品系列的研发路径和临床相关性至关重要。根据产品类型，该领域包括心肺体外迴圈系统和体外膜氧合（ECMO）平台。心肺体外迴圈解决方案提供整合式和独立式两种形式，而ECMO则分别采用静脉-动脉和静脉-静脉模式，以适应不同的心臟和呼吸系统适应症。每类产品都有其独特的设计、灭菌和临床培训要求，这些要求会影响其在医疗机构中的部署模式。

了解美洲、欧洲、中东、非洲和亚太地区在法规、临床实务和采购模式方面的差异，并将这些差异反映到每个地区的商业化策略中。

区域趋势对体外循环领域的监管方式、采购行为和临床实务模式有显着影响。在美洲，集中化的报销机制和对实证医学的重视促使製造商投资于临床试验和上市后监测，而医疗服务提供者则优先选择那些能够展现出明确营运效益和患者疗效的器械。此外，该地区也倾向于与当地分销商建立策略合作伙伴关係，以便能够快速回应高优先级医疗中心的需求。

我们评估由系统整合、组件创新、临床证据的产生以及供应链中的策略定位所驱动的竞争差异化。

体外循环系统领域的竞争格局呈现出成熟设备产品组合与专业工程公司快速创新并存的态势，伙伴关係、收购和共同开发契约已成为常态。老牌製造商凭藉其品牌知名度和全球服务网络，继续为医院和专科心臟中心提供产品；而新兴参与企业则透过专注于改进泵浦技术、氧合膜以及降低手术复杂性的耗材设计，挑战现有企业的生存空间。

为製造商和医疗保健系统提供切实可行的策略，以加速采用体外循环系统，增强供应韧性，并加强临床证据。

体外循环领域的领导企业应采取一系列切实可行的措施，在最大限度地发挥技术优势的同时，降低营运和政策风险。应优先投资于血液相容性材料、低预充液设计以及模组化架构，以便快速重新配置为静脉-动脉 (VA) 或静脉-静脉 (VV) 支援。这样做将减轻临床医生的负担，并扩大其在心臟外科手术和呼吸支持等领域的应用范围。

本文说明了一种多方面的调查方法，该方法结合了对临床医生的访谈、技术整合和数据的三角检验，从而对医疗设备和临床实践的趋势提供了检验的见解。

本执行摘要的调查方法结合了第一手定性研究和全面的二手资料，确保了研究结果的可靠性和可重复性。第一手资料包括对第一线心臟外科医生和重症监护临床医生、医院和专科诊所的采购经理以及医疗设备製造商的高级工程领导进行的结构化访谈。访谈内容主要围绕临床工作流程、装置性能特征、采购限制以及预期技术进步。

本报告总结了临床需求、组件创新和政策因素的融合，这些因素将决定体外循环解决方案的可扩展部署。

总之，体外循环领域正迈入一个以系统整合、组件层级改进以及对实证医学和供应稳定性日益增长的需求为特征的阶段。临床上对可靠的静脉-动脉（VA）和静脉-静脉（VV）配置的需求，以及对能够最大限度减少血液负荷并简化工作流程的泵和氧合器的偏好，持续影响着产品蓝图。同时，政策变化和区域采购趋势正迫使製造商和供应商重新评估其采购、生产和商业化策略。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 体外循环系统市场：依产品类型划分

  • 心肺体外迴圈系统
    • 整合系统
    • 独立系统
  • 体外膜氧合（ECMO）
    • VA-ECMO
    • VV-ECMO

第九章 体外循环系统市场：依组件划分

  • 热交换器
    • 板式热交换器
    • 管式热交换器
  • 氧合器
    • 中空纤维氧气净化器
    • 膜式氧合器
  • 泵浦
    • 离心式帮浦
    • 磁浮泵浦
    • 滚筒帮浦
  • 管子
    • PVC管
    • 硅胶管

第十章 体外循环系统市场：依技术划分

  • 离心式帮浦
  • 磁浮泵浦
  • 滚筒帮浦

第十一章 体外循环系统市场：依应用划分

  • 心臟外科手术
    • 冠状动脉绕道手术手术
    • 瓣膜置换术
    • 血管外科
  • 呼吸辅助
    • 急性呼吸窘迫症候群
    • 弥合移植差距
    • ECMO治疗COVID-19

第十二章 体外循环系统市场：依最终用户划分

  • 门诊手术中心
  • 医院
    • 综合医院
    • 心臟科中心
  • 专科诊所
    • 儿童医疗中心
    • 研究机构

第十三章 体外循环系统市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 体外循环系统市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 体外循环系统市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国：体外循环系统市场

第十七章 中国：体外循环系统市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Accumed Technologies Inc.
  • Becton Dickinson and Company
  • Beijing Balance Medical Co. Ltd.
  • Braile Biomedica
  • Chalice Medical Ltd.
  • Eurosets Srl
  • Getinge AB
  • Kewei Medical Apparatus Co. Ltd.
  • LivaNova PLC
  • MAQUET Cardiopulmonary AG
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Nipro Medical Corporation
  • Senko Medical Instrument Mfg. Co. Ltd.
  • Spectrum Medical Ltd.
  • Terumo Corporation
  • Tianjin Medical Equipment Co. Ltd.
  • Tianjin XinHaoShun Scientific & Trade Co. Ltd.
  • Weigao Group
Product Code: MRR-CD5A9334D17A

The Extracorporeal Circulation System Market was valued at USD 1.58 billion in 2025 and is projected to grow to USD 1.70 billion in 2026, with a CAGR of 8.36%, reaching USD 2.78 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.58 billion
Estimated Year [2026] USD 1.70 billion
Forecast Year [2032] USD 2.78 billion
CAGR (%) 8.36%

Framing the evolving clinical and technological imperatives that define extracorporeal circulation systems and influence procurement and adoption decisions

The contemporary field of extracorporeal circulation systems occupies a central role at the intersection of cardiac surgery and advanced respiratory support, powered by continuous technological refinement and evolving clinical protocols. Recent years have seen intensified focus on both cardiopulmonary bypass equipment and extracorporeal membrane oxygenation platforms as hospitals and specialty centers expand capabilities to manage complex cardiac operations and severe respiratory failure. This introductory overview frames the ecosystem by emphasizing clinical drivers, component-level innovation, and the policy context that shapes procurement and adoption decisions.

Clinicians increasingly demand systems that integrate safety features, ease of priming, and streamlined workflow to reduce operative time and improve patient throughput. Simultaneously, manufacturers pursue miniaturization, improved biocompatibility, and modular architectures that permit rapid configuration for diverse indications. Payers and health systems are pressing for demonstrable clinical value, which elevates the importance of outcomes-based evidence and procedures that shorten intensive care utilization. Therefore, stakeholders should view extracorporeal circulation not simply as hardware, but as a clinical service bundle comprising devices, disposables, training, and post-market support.

Moving forward, decision-makers must weigh clinical effectiveness, operational efficiency, and lifecycle cost while navigating regulatory expectations and supply chain resiliency. In doing so, they can align investments with institutional priorities to enhance patient safety and sustain high-acuity services across care settings.

Identifying the technological advances, clinical practice evolution, and regulatory pressures that are rapidly reshaping extracorporeal circulation system development and adoption

The landscape surrounding extracorporeal circulation is undergoing transformative shifts driven by innovation in pump technologies, oxygenator design, and systems integration, alongside changing clinical practice patterns and regulatory emphasis on safety and real-world performance. Centrifugal and magnetic levitation pumps have gained traction due to reduced hemolysis and improved flow control, while oxygenator advancements focus on gas exchange efficiency and thromboresistance. These engineering improvements enable newer system architectures that favor integrated solutions, portable platforms, and disposable component strategies that lower cross-contamination risk.

Clinical protocols are adapting as extracorporeal membrane oxygenation expands beyond traditional indications. Use in severe respiratory failure and as a bridge to transplant has created demand for flexible venoarterial and venovenous configurations that can be rapidly deployed in intensive care and perioperative environments. In parallel, hospitals emphasize shorter pump run times and faster recovery, which elevates the importance of device ergonomics, rapid setup, and intuitive monitoring interfaces.

Regulatory bodies increasingly require post-market surveillance, clinical data submission, and traceability for critical components. This regulatory tightening encourages manufacturers to invest in quality systems and clinical evidence generation. Additionally, supply chain resilience has ascended as a strategic priority following disruptions, prompting diversification of manufacturing footprints and stronger supplier relationships. Taken together, these forces are pushing the sector toward systems that are safer, more adaptable, and better aligned with contemporary care pathways.

Understanding how recent tariff developments and trade policy shifts contribute to sourcing realignment, cost rebalancing, and strategic manufacturing responses in the sector

The cumulative effect of tariff adjustments, trade policy revisions, and import restrictions implemented in the United States during 2025 introduces a material layer of complexity for manufacturers, distributors, and end users in the extracorporeal circulation ecosystem. Tariff changes on imported medical components and finished devices can alter landed costs, prompt re-evaluation of sourcing strategies, and accelerate relocation or nearshoring of production capabilities. Organizations with global supply chains must therefore reconcile cross-border procurement practices with the new duty environment.

In practice, increased import duties incentivize higher domestic content in assemblies, which can lead to capital investment in local manufacturing or partnerships with U.S.-based contract manufacturers. While such efforts can improve supply reliability and reduce exposure to logistic disruptions, they also require time and capital to qualify alternate suppliers and to ensure regulatory compliance for devices and components. Hospitals and specialty clinics might experience short-term procurement friction as distributors adjust pricing and inventory policies, but they may also benefit from improved vendor transparency and shorter lead times over the medium term.

Policy-driven cost pressures further motivate device makers to accelerate design changes that lower material intensity, enhance modularity, and enable regionalized production. In sum, organizations should anticipate a transition period marked by cost rebalancing, supplier consolidation, and strategic investments aimed at long-term resilience and alignment with the revised trade landscape.

Dissecting product, component, technology, application, and end-user segmentation to reveal differentiated clinical needs and industrial strategic pathways

A nuanced understanding of segmentation is essential to interpret product development pathways and clinical alignment across extracorporeal circulation offerings. Based on product type, the landscape encompasses cardiopulmonary bypass systems and extracorporeal membrane oxygenation platforms; cardiopulmonary bypass solutions present as integrated systems as well as standalone systems, while extracorporeal membrane oxygenation is deployed in venoarterial and venovenous modalities tailored to cardiac and respiratory indications respectively. Each product class imposes distinct engineering, sterilization, and clinical training requirements, which in turn influence adoption patterns across institutions.

Component-level segmentation clarifies technology supply chains and clinical performance trade-offs. Heat exchangers are available as plate and tubular designs with different thermal efficiencies and priming volumes; oxygenators are realized through hollow fiber and membrane constructions that vary in gas exchange properties; pumps include centrifugal, magnetic levitation, and roller formats that drive differences in shear stress and maintenance needs; tubing options span PVC and silicone, each with discrete biocompatibility and handling characteristics. These component choices shape device lifetime, disposables strategies, and clinician preferences.

Technology segmentation further highlights that centrifugal, magnetic levitation, and roller pump approaches each present unique benefits vis-a-vis hemocompatibility, footprint, and integration complexity, thereby guiding R&D investment. Application segmentation distinguishes cardiac surgery indications such as coronary artery bypass grafting, valve replacement, and vascular surgery from respiratory support use cases including acute respiratory distress syndrome, bridge to transplant, and COVID-related ECMO deployment. Finally, end-user segmentation differentiates ambulatory surgery centers with cardiac day surgery workflows, hospitals comprising general and specialized cardiac centers, and specialty clinics such as pediatric centers and research institutes. Together, these intersecting segmentation vectors create a multi-dimensional picture that informs product positioning, service design, and go-to-market strategies.

Mapping divergent regulatory, clinical, and procurement patterns across the Americas, Europe Middle East and Africa, and Asia Pacific to inform regional commercialization strategies

Regional dynamics exert a powerful influence on regulatory approach, procurement behavior, and clinical practice patterns across the extracorporeal circulation domain. In the Americas, centralized reimbursement frameworks and a strong emphasis on evidence-based adoption encourage manufacturers to invest in clinical trials and post-market studies while healthcare providers prioritize devices that demonstrate clear operational and patient outcome benefits. This region also favors strategic partnerships with local distributors to maintain rapid response capabilities for high-acuity centers.

In Europe, Middle East & Africa, regulatory environments vary considerably, prompting manufacturers to maintain flexible regulatory and market access teams that can navigate divergent approval pathways and reimbursement regimes. Clinical preferences often reflect a balance between cost containment and the adoption of advanced technology, which spurs modular solutions that can be tailored by facility capability. Supply chain fragmentation across the region incentivizes partnerships with regional logistics specialists and local service providers to ensure continuity of consumables and maintenance.

Across Asia-Pacific, rapid capacity expansion of specialty hospitals and increasing investment in tertiary cardiac and respiratory programs are driving demand for both integrated systems and component supplies. Regulatory modernization and rising clinical expertise support adoption of advanced pump and oxygenator technologies, while domestic manufacturing in several countries contributes to competitive pricing dynamics. Stakeholders should therefore adopt region-specific strategies that align product configurations, training programs, and service models with local clinical workflows and procurement practices.

Evaluating competitive differentiation driven by systems integration, component innovation, clinical evidence generation, and supply chain strategic positioning

Competitive dynamics within extracorporeal circulation systems combine legacy device portfolios with rapid innovation from specialized engineering firms, creating a landscape in which partnerships, acquisitions, and co-development agreements are common. Established manufacturers continue to leverage brand recognition and global service networks to supply hospitals and specialized cardiac centers, while emerging entrants challenge incumbents through focused improvements in pump technology, oxygenator membranes, and disposable consumable design that reduce procedural complexity.

Strategic differentiation increasingly centers on systems integration, clinician training services, and digital monitoring capabilities that provide real-time performance data and enable preventive maintenance. Companies that invest in end-to-end solutions-comprising hardware, disposables, software-enabled analytics, and education programs-tend to secure longer-term relationships with health systems. At the same time, component suppliers that offer low-volume customization and rapid prototyping are attractive partners for original equipment manufacturers seeking to accelerate product enhancements.

Supply chain control is another axis of competition; firms that maintain diversified manufacturing footprints and deep supplier relationships for critical materials are better positioned to manage disruptions and tariff impacts. Regulatory expertise and a robust clinical evidence base further amplify competitive advantage, as payers and provider procurement teams increasingly favor suppliers who can demonstrate outcomes and support across the product lifecycle.

Actionable strategies for manufacturers and health systems to accelerate adoption, build supply resilience, and strengthen clinical evidence supporting extracorporeal systems

Leaders in the extracorporeal circulation space should adopt a set of pragmatic actions to capitalize on technological momentum while mitigating operational and policy risks. Prioritize investments in hemocompatible materials, low-prime-volume designs, and modular architectures that enable rapid reconfiguration for venoarterial or venovenous support. By doing so, manufacturers can reduce clinician burden and broaden the addressable clinical use cases across cardiac surgery and respiratory support.

Concurrently, develop regional manufacturing and packaging strategies to mitigate tariff exposure and improve lead times. Establishing validated partnerships with contract manufacturers in key geographies or enhancing domestic assembly capabilities will reduce supply fragility. Complementing these moves with robust inventory planning and multi-sourcing for critical components will further insulate operations from disruption.

Strengthen clinical evidence generation through targeted registries and pragmatic clinical studies focused on outcomes such as hemolysis rates, oxygenation efficiency, and device-related complication reduction. Invest in clinician training programs and simulation-based curricula to accelerate safe adoption and to build preference for your systems. Finally, engage proactively with regulators and payers to align product labeling, reimbursement coding, and post-market surveillance expectations, which will smooth market access and support longer-term commercial sustainability.

Explaining the multi-source research approach that combines clinician interviews, technical synthesis, and data triangulation to deliver validated insights into device and clinical practice dynamics

The research methodology underpinning this executive summary integrates a blend of primary qualitative inquiry and comprehensive secondary source synthesis to ensure robust, reproducible insights. Primary inputs included structured interviews with practicing cardiac and critical care clinicians, procurement executives from hospitals and specialty clinics, and senior engineering leaders within device firms. These conversations focused on clinical workflows, device performance attributes, procurement constraints, and anticipated technology trajectories.

Secondary research encompassed regulatory filings, peer-reviewed clinical literature, device technical specifications, and policy documents to validate technical claims and to contextualize regional regulatory differences. Data triangulation techniques were applied to reconcile divergent viewpoints and to identify consistent patterns across clinical settings and geographies. The analysis also incorporated component-level technical comparison to illuminate trade-offs between pump types, oxygenator constructions, and material choices.

Quality assurance included cross-validation of key findings with independent clinical advisors and iterative review cycles to refine interpretations. Limitations pertain to rapidly evolving clinical practice and potential variability in local procurement policies; nonetheless, the methodological approach prioritizes transparency and traceability to support confident decision-making by stakeholders.

Summarizing the convergence of clinical demand, component innovation, and policy drivers that will determine the scalable adoption of extracorporeal circulation solutions

In conclusion, the extracorporeal circulation domain is transitioning to a phase characterized by integrated systems, component-level refinement, and heightened expectations for evidence and supply resilience. Clinical demand for reliable venoarterial and venovenous configurations, coupled with preferences for pumps and oxygenators that minimize blood trauma and streamline workflows, continues to shape product roadmaps. At the same time, policy changes and regional procurement dynamics compel manufacturers and providers to reassess sourcing, manufacturing, and commercialization strategies.

Stakeholders who align product design with clinician needs, invest in demonstrable clinical outcomes, and build flexible supply networks will secure competitive advantage while enhancing patient safety and institutional readiness for complex cardiac and respiratory cases. The interplay between technological innovation, regulatory diligence, and operational execution will determine which solutions scale effectively across diverse care settings, from ambulatory cardiac day surgery facilities to tertiary referral centers and specialized pediatric programs.

Overall, a strategic focus on modularity, evidence generation, and regional alignment will enable durable adoption of extracorporeal circulation capabilities that meet contemporary clinical and organizational imperatives.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Extracorporeal Circulation System Market, by Product Type

  • 8.1. Cardiopulmonary Bypass System
    • 8.1.1. Integrated Systems
    • 8.1.2. Standalone Systems
  • 8.2. Extracorporeal Membrane Oxygenation
    • 8.2.1. Venoarterial Ecmo
    • 8.2.2. Venovenous Ecmo

9. Extracorporeal Circulation System Market, by Component

  • 9.1. Heat Exchanger
    • 9.1.1. Plate Heat Exchanger
    • 9.1.2. Tubular Heat Exchanger
  • 9.2. Oxygenator
    • 9.2.1. Hollow Fiber Oxygenator
    • 9.2.2. Membrane Oxygenator
  • 9.3. Pump
    • 9.3.1. Centrifugal Pump
    • 9.3.2. Magnetic Levitation Pump
    • 9.3.3. Roller Pump
  • 9.4. Tubing
    • 9.4.1. Pvc Tubing
    • 9.4.2. Silicone Tubing

10. Extracorporeal Circulation System Market, by Technology

  • 10.1. Centrifugal Pump
  • 10.2. Magnetic Levitation Pump
  • 10.3. Roller Pump

11. Extracorporeal Circulation System Market, by Application

  • 11.1. Cardiac Surgery
    • 11.1.1. Coronary Artery Bypass Grafting
    • 11.1.2. Valve Replacement
    • 11.1.3. Vascular Surgery
  • 11.2. Respiratory Support
    • 11.2.1. Acute Respiratory Distress Syndrome
    • 11.2.2. Bridge To Transplant
    • 11.2.3. Covid Ecmo

12. Extracorporeal Circulation System Market, by End User

  • 12.1. Ambulatory Surgery Centers
  • 12.2. Hospitals
    • 12.2.1. General Hospitals
    • 12.2.2. Specialized Cardiac Centers
  • 12.3. Specialty Clinics
    • 12.3.1. Pediatric Centers
    • 12.3.2. Research Institutes

13. Extracorporeal Circulation System Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Extracorporeal Circulation System Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Extracorporeal Circulation System Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Extracorporeal Circulation System Market

17. China Extracorporeal Circulation System Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Accumed Technologies Inc.
  • 18.6. Becton Dickinson and Company
  • 18.7. Beijing Balance Medical Co. Ltd.
  • 18.8. Braile Biomedica
  • 18.9. Chalice Medical Ltd.
  • 18.10. Eurosets S.r.l.
  • 18.11. Getinge AB
  • 18.12. Kewei Medical Apparatus Co. Ltd.
  • 18.13. LivaNova PLC
  • 18.14. MAQUET Cardiopulmonary AG
  • 18.15. Medtronic plc
  • 18.16. MicroPort Scientific Corporation
  • 18.17. Nipro Medical Corporation
  • 18.18. Senko Medical Instrument Mfg. Co. Ltd.
  • 18.19. Spectrum Medical Ltd.
  • 18.20. Terumo Corporation
  • 18.21. Tianjin Medical Equipment Co. Ltd.
  • 18.22. Tianjin XinHaoShun Scientific & Trade Co. Ltd.
  • 18.23. Weigao Group

LIST OF FIGURES

  • FIGURE 1. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY INTEGRATED SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY INTEGRATED SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY INTEGRATED SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY STANDALONE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY STANDALONE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY STANDALONE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VENOARTERIAL ECMO, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VENOARTERIAL ECMO, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VENOARTERIAL ECMO, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VENOVENOUS ECMO, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VENOVENOUS ECMO, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VENOVENOUS ECMO, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HEAT EXCHANGER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HEAT EXCHANGER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HEAT EXCHANGER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HEAT EXCHANGER, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PLATE HEAT EXCHANGER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PLATE HEAT EXCHANGER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PLATE HEAT EXCHANGER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBULAR HEAT EXCHANGER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBULAR HEAT EXCHANGER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBULAR HEAT EXCHANGER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY OXYGENATOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY OXYGENATOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY OXYGENATOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY OXYGENATOR, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOLLOW FIBER OXYGENATOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOLLOW FIBER OXYGENATOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOLLOW FIBER OXYGENATOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY MEMBRANE OXYGENATOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY MEMBRANE OXYGENATOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY MEMBRANE OXYGENATOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PUMP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PUMP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PUMP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PUMP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CENTRIFUGAL PUMP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CENTRIFUGAL PUMP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CENTRIFUGAL PUMP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY MAGNETIC LEVITATION PUMP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY MAGNETIC LEVITATION PUMP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY MAGNETIC LEVITATION PUMP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY ROLLER PUMP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY ROLLER PUMP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY ROLLER PUMP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PVC TUBING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PVC TUBING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PVC TUBING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SILICONE TUBING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SILICONE TUBING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SILICONE TUBING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CENTRIFUGAL PUMP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CENTRIFUGAL PUMP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CENTRIFUGAL PUMP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY MAGNETIC LEVITATION PUMP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY MAGNETIC LEVITATION PUMP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY MAGNETIC LEVITATION PUMP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY ROLLER PUMP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY ROLLER PUMP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY ROLLER PUMP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIAC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIAC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIAC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIAC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VALVE REPLACEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VALVE REPLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VALVE REPLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VASCULAR SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VASCULAR SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VASCULAR SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESPIRATORY SUPPORT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESPIRATORY SUPPORT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESPIRATORY SUPPORT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY ACUTE RESPIRATORY DISTRESS SYNDROME, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY ACUTE RESPIRATORY DISTRESS SYNDROME, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY ACUTE RESPIRATORY DISTRESS SYNDROME, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COVID ECMO, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COVID ECMO, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COVID ECMO, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY GENERAL HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY GENERAL HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALIZED CARDIAC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALIZED CARDIAC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALIZED CARDIAC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PEDIATRIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PEDIATRIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PEDIATRIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. AMERICAS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 130. AMERICAS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. AMERICAS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 132. AMERICAS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 133. AMERICAS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 134. AMERICAS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HEAT EXCHANGER, 2018-2032 (USD MILLION)
  • TABLE 135. AMERICAS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY OXYGENATOR, 2018-2032 (USD MILLION)
  • TABLE 136. AMERICAS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PUMP, 2018-2032 (USD MILLION)
  • TABLE 137. AMERICAS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 138. AMERICAS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 139. AMERICAS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. AMERICAS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIAC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 141. AMERICAS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 142. AMERICAS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. AMERICAS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 144. AMERICAS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. NORTH AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HEAT EXCHANGER, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY OXYGENATOR, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PUMP, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIAC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HEAT EXCHANGER, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY OXYGENATOR, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PUMP, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. LATIN AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIAC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 174. LATIN AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HEAT EXCHANGER, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY OXYGENATOR, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PUMP, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIAC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HEAT EXCHANGER, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY OXYGENATOR, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PUMP, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIAC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HEAT EXCHANGER, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY OXYGENATOR, 2018-2032 (USD MILLION)
  • TABLE 216. MIDDLE EAST EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PUMP, 2018-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 218. MIDDLE EAST EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 220. MIDDLE EAST EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIAC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 222. MIDDLE EAST EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 223. MIDDLE EAST EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 224. MIDDLE EAST EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 230. AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HEAT EXCHANGER, 2018-2032 (USD MILLION)
  • TABLE 231. AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY OXYGENATOR, 2018-2032 (USD MILLION)
  • TABLE 232. AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PUMP, 2018-2032 (USD MILLION)
  • TABLE 233. AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 234. AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 235. AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 236. AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIAC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 237. AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 238. AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 239. AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 240. AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 245. ASIA-PACIFIC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 246. ASIA-PACIFIC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HEAT EXCHANGER, 2018-2032 (USD MILLION)
  • TABLE 247. ASIA-PACIFIC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY OXYGENATOR, 2018-2032 (USD MILLION)
  • TABLE 248. ASIA-PACIFIC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PUMP, 2018-2032 (USD MILLION)
  • TABLE 249. ASIA-PACIFIC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 250. ASIA-PACIFIC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 251. ASIA-PACIFIC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 252. ASIA-PACIFIC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIAC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 253. ASIA-PACIFIC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 254. ASIA-PACIFIC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 255. ASIA-PACIFIC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 256. ASIA-PACIFIC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 257. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 258. ASEAN EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 259. ASEAN EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. ASEAN EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 261. ASEAN EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 262. ASEAN EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 263. ASEAN EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HEAT EXCHANGER, 2018-2032 (USD MILLION)
  • TABLE 264. ASEAN EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY OXYGENATOR, 2018-2032 (USD MILLION)
  • TABLE 265. ASEAN EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PUMP, 2018-2032 (USD MILLION)
  • TABLE 266. ASEAN EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 267. ASEAN EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 268. ASEAN EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 269. ASEAN EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIAC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 270. ASEAN EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 271. ASEAN EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 272. ASEAN EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 273. ASEAN EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 274. GCC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 275. GCC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 276. GCC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 277. GCC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 278. GCC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 279. GCC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HEAT EXCHANGER, 2018-2032 (USD MILLION)
  • TABLE 280. GCC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY OXYGENATOR, 2018-2032 (USD MILLION)
  • TABLE 281. GCC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PUMP, 2018-2032 (USD MILLION)
  • TABLE 282. GCC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 283. GCC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)

TABLE 2